Prenetics Global signs "transformational" $200mln deal to create cancer screening JV

By: News Direct

June 30, 2023 at 08:00 AM EDT

--News Direct--

Prenetics Global Ltd (NASDAQ: PRE) CEO Danny Yeung speaks to Thomas Warner from Proactive after announcing a $200mln deal to create a multi-cancer early detection screening joint venture with Professor Dennis Lo. The new JV will be called Insighta and Yeung will serve as its first CEO. Yeung reveals plans to launch tests targeting lung and liver cancer in 2025, with a goal of selling over 30 million tests annually by 2030.

Contact Details

Proactive United States

Proactive United States

+1 347-449-0879

action@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/prenetics-global-signs-transformational-200mln-deal-to-create-cancer-screening-jv-764359654

More News

3 Stocks Poised to Benefit From Google’s AI Breakthough ↗

Today 18:22 EST

Via MarketBeat

Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026 ↗

Today 17:23 EST

Via MarketBeat

3 Stocks You’ll Wish You Bought Before 2026 ↗

Today 16:43 EST

Via MarketBeat

Wall Street Punished CrowdStrike for Beating Earnings? Seriously? ↗

Today 15:12 EST

Via MarketBeat

Okta: Excuses to Sell Vs. Reasons to Buy ↗

Today 14:45 EST

Via MarketBeat

Recent Quotes

Symbol	Price	Change (%)
AMZN	232.38	-2.04 (-0.87%)
AAPL	284.15	-2.04 (-0.71%)
AMD	217.60	+2.36 (1.10%)
BAC	54.09	+0.90 (1.69%)
GOOG	320.62	+4.60 (1.46%)
META	639.60	-7.50 (-1.16%)
MSFT	477.73	-12.27 (-2.50%)
NVDA	179.59	-1.87 (-1.03%)
ORCL	207.73	+6.63 (3.30%)
TSLA	446.74	+17.50 (4.08%)

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.